Proton beam therapy is an advanced form of external radiotherapy that uses high-energy proton beams instead of photon x-ray beams or electrons. Carefully measured doses of protons are delivered to the precise area needing treatment, using the latest IBA ProteusONE technology. This ensures that the delivery of proton beam therapy is highly accurate and prevents the risk of radiation reaching surrounding healthy tissue.
Radiotherapy is used to kill and destroy cancer cells. It utilises radiation in the form of high-energy x-rays, known as photons, to kill and damage the cancerous cells and prevent their growth and reproduction. It can be used as a non-surgical option to treat cancer, and it can also be used to shrink a tumour or in combination with other treatments.
We provide a chemotherapy treatment service that offers you both choice and flexibility. Chemotherapy is the use of cytotoxic (anti-cancer) drugs to destroy cancer cells in the body by disrupting the cancer cells and preventing them from growing and dividing.
Dr Chris Herbert qualified in medicine at Birmingham University in 2000. He trained in Clinical Oncology in Bristol and completed his oncology training as a clinical research fellow at the British Columbia Cancer Agency in Vancouver, Canada, where he specialised in stereotactic radiosurgery and the treatment of benign and malignant adult brain tumours. Appointed as consultant Clinical Oncologist in Bristol in 2011, he has an interest in technical radiotherapy, specialising in the treatment of adult brain tumours, including stereotactic radiosurgery and proton therapy.
He also has an interest in the treatment of malignant melanoma with immunotherapy and targeted treatments and has been involved in numerous international clinical trials. He has published work on stereotactic radiosurgery and external beam radiotherapy in international, peer reviewed journals.
Dr Herbert's areas of research interests include:
Fellow of Royal college of Radiologists
Dr Christopher Herbert does not hold a share or financial interest in the Rutherford Cancer Centres or another Rutherford Health plc company.
Dr Christopher Herbert does not have a share or financial interest in equipment used at the Rutherford Cancer Centres or another Rutherford Health plc company.
Dr Christopher Herbert does not hold any paid advisory role(s) at the Rutherford Cancer Centres or on behalf of Rutherford Cancer Centres or Rutherford Health plc.
Get in Touch
If you'd like to speak to us about any of the treatments we offer please don’t hesitate to get in touch. Call us on 0800 210 0402 or